As of December 1, 2018, All Medically Important Antimicrobials for Veterinary Use will be Sold by Prescription Only

October 10, 2017

Health Canada is moving a number of Medically Important Antimicrobials (MIAs) approved for veterinary use before 2004 to the Prescription Drug List (PDL). With this change, Health Canada will establish the same level of oversight for those MIAs approved before 2004 as for those approved after.

As of December 1, 2018, all MIAs for veterinary use will be on the PDL and must be sold by prescription only.

Timelines for the changes

Until December 1, 2018, the drugs listed in the ‘Prescription status – affected drugs and dosage forms’ section will not be prescription status.

As of December 1, 2018, the drugs listed in the ‘Prescription status – affected drugs and dosage forms’ section will be prescription status.

Beginning early 2018, you may start to see some label changes on the market during the transition between old and new labels.

Read more here.

Who we are working with

The Canadian Veterinary Medical Association (CVMA), along with other stakeholders, have been engaging with the Veterinary Drug Directorate about these changes and will continue to support these actions with ongoing engagement and communication.

Throughout 2016, CVMA in partnership with the Canadian Council of Veterinary Registrars (CCVR), provided key relevant information to help increase awareness of key issues and new developments as the new regulations are finalized and implemented. Find more information here.

After broad stakeholder consultation and discussion, the CCVR and the CVMA’s Veterinary Pharmaceutical Stewardship Advisory Group developed a pan-Canadian framework of professional standards for veterinarians regarding veterinary oversight of antimicrobial use. It is available for download here.